Provided by Tiger Fintech (Singapore) Pte. Ltd.

Enanta Pharmaceuticals

6.44
+0.14002.22%
Post-market: 6.440.00000.00%16:05 EDT
Volume:154.61K
Turnover:977.41K
Market Cap:137.38M
PE:-1.30
High:6.47
Open:6.34
Low:6.11
Close:6.30
Loading ...

BRIEF-Enanta Pharmaceuticals Q4 Revenue USD 14.607 Million Vs. IBES Estimate USD 17.9 Million

Reuters
·
26 Nov 2024

Enanta Pharmaceuticals Q4 Pretax Profit USD -29.186 Million

THOMSON REUTERS
·
26 Nov 2024

Enanta Pharmaceuticals Reports Financial Results for Its Fiscal Fourth Quarter and Year-Ended September 30, 2024

THOMSON REUTERS
·
26 Nov 2024

Enanta Pharmaceuticals Reports Financial Results for its Fiscal Fourth Quarter and Year-Ended September 30, 2024

Business Wire
·
26 Nov 2024

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
25 Nov 2024

Enanta Pharmaceuticals Inc expected to post a loss of $1.16 a share - Earnings Preview

Reuters
·
23 Nov 2024

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
21 Nov 2024

The past three years for Enanta Pharmaceuticals (NASDAQ:ENTA) investors has not been profitable

Simply Wall St.
·
27 Oct 2024

Enanta Pharmaceuticals (ENTA): Promising Clinical Stage Biotech with Robust Pipeline

Insider Monkey
·
19 Oct 2024

Millennium Management LLC's Strategic Acquisition of Enanta Pharmaceuticals Shares

GuruFocus.com
·
18 Oct 2024

Enanta Pharmaceuticals Price Target Maintained With a $22.00/Share by JMP Securities

Dow Jones
·
10 Oct 2024

Buy Rating for Enanta Pharmaceuticals Amid Reduced Competition and Promising Drug Trials

TIPRANKS
·
09 Oct 2024

Enanta Pharmaceuticals (ENTA) Surges 5.6%: Is This an Indication of Further Gains?

Zacks
·
02 Oct 2024

Analysts Offer Insights on Healthcare Companies: Enanta Pharmaceuticals (ENTA) and Resmed (RMD)

TIPRANKS
·
28 Sep 2024

Enanta Pharmaceuticals (ENTA) Gets a Hold from Leerink Partners

TIPRANKS
·
28 Sep 2024

Enanta Pharmaceuticals Price Target Maintained With a $22.00/Share by JMP Securities

Dow Jones
·
27 Sep 2024